NucleaRDB: Extraction of mutation data from the literature

logo    2005, NucleaRDB.


This data was extracted from Medline abstracts and full texts (when available) in an automated manner.

The table below describes different point mutations at a given position and provides links to other documents. The sentence(s) where the point mutations in NR1I3_MOUSE at position 355 were found are listed after the table.


Point mutations at position E355 in NR1I3_MOUSE

ProteinNR1I3_MOUSE (O35627)    Gene: Nr1i3,Ca    (other point mutations)Swiss-Prot
Cross-reference table
Family page
Protein isoforms2
PositionE355
General numbering (NucleaRDB) 1250
DomainLBD HELIX 12
Family alignments 1I3 Constitutive Androstane alpha (CAR1)
1I Vitamin D3-like (VDR,PXR,CAR)
1 Thyroid hormone like (TR,RAR,ROR,PPAR,VDR
Other point mutations at the same position Position 355 in 1I3 Constitutive Androstane alpha (CAR1) family
Position 415 in 1I Vitamin D3-like (VDR,PXR,CAR) family
Position 403 in 1 Thyroid hormone like (TR,RAR,ROR,PPAR,VDR family
Reference #1Ueda A, Kakizaki S, Negishi M, Sueyoshi T
Mol Pharmacol 2002 Jun;61(6):1284-8.
Medline
Text sourceHTML and PDF full texts
Point mutationE355A (True positive)
Cited point mutationGlu355Ala
Reference #2Dussault I, Lin M, Hollister K, Fan M, Termini J, Sherman MA, Forman BM
Mol Cell Biol 2002 Aug;22(15):5270-80.
Medline
Text sourceHTML and PDF full texts
Point mutationE355A (True positive)
Reference #3Andersin T, Vaisanen S, Carlberg C
Mol Endocrinol 2003 Feb;17(2):234-46.
Medline
Text sourceHTML full text
Point mutationE355A (True positive)

Relevant sentences

Reference #2 (Dussault I et al.): E355A
  • CMX-CAR L352A and CAR E355A were constructed by replacing the BspEI / NheI fragment of CAR with synthetic oligonucleotides corresponding to amino acids 329 to 358 of CAR , encoding an alanine at either position 352 or 355 of the H12 / AF2 domain

  • To address this question , we mutated conserved amino acid residues in H12 / AF2 (L352A and E355A) and H3 (K187A) that contribute to the hydrophobic coregulator cleft on the surface of ligand-bound nuclear receptors (8 , 11 , 37 , 43 )

  • In contrast , mutations in either the H12 / AF2 domain (L352A and E355A) or H3 (K187A) completely inhibited constitutive activity , and TCPOBOP failed to restore activity to wild-type levels (Fig. 1A )

  • Single point mutations in H12 / AF2 (L352A or E355A) or H3 (K187A) specifically resulted in the complete loss of both constitutive and ligand-induced SRC-1 recruitment (Fig. 1B , lanes 4 to 9)

  • Moreover , the ability to selectively abolish constitutive activity in this mutant but not others (K205 , L352A , and E355A) (Fig. 1A and B ; Fig. 5A and B ) implies that constitutive and agonist-inducible activity have both distinct and overlapping determinants

  • In contrast , mutations in either the H12 / AF2 domain (L352A and E355A) or H3 (K187A) completely inhibited constitutive ac
    FIG

Reference #3 (Andersin T et al.): E355A
  • The point mutants L352A , L353A , E355A , I356A , and C357A and the AF-2 deletion reduced the basal activity by 90% or more , S358A by 75% , and G354A by only 10%

  • These include the reduced TCPOBOP inducibility of C357A (only 10.5-fold) and reduced loss of basal activity of E355A (only 80%) and S358A (only 60%) compared with wild-type CAR

  • E355A and S358A also resemble the profile of wild-type CAR , but their overall weaker interaction with TIF2 is shown by the reduced migratory distances between the supershifted complex (CAR-RXR-TIF2-DNA) and the gel shift complex (CAR-RXR-DNA)

  • Using standard nonsaturating TIF2 amounts (0.1 µg) , both K187A and E355A displayed a clear interaction with TIF2 in the absence of ligand

  • B , Heterodimers of in vitro translated CARK187A and CARE355A protein with RXR protein were formed in the presence of solvent , TCPOBOP , androstanol , or a combination of both

Reference #1 (Ueda A et al.): Glu355Ala
  • mCAR lost its constitutive activity after an AF2 mutation (Leu352Ala or Glu355Ala) or an AF2 deletion in a cell-based transfection assay (Choi et al. , 1997(image) )

  • mCAR lost its constitutive activity after an AF2 mutation (Leu352Ala or Glu355Ala) or an AF2 deletion in a cell-based transfection assay (Choi et al. , 1997)


Button bar
F.Horn (nucleardbcmbi.kun.nl), 21-Apr-2005